MILWAUKEE, March 8, 2024 – ConsortiEX, a leader in compliance and patient-safety focused software and services for outsourcing and hospital pharmacies, is pleased to announce a new strategic partnership with LedgerDomain, a pioneering identity and secure messaging platform tailored for modern decentralized healthcare. This collaboration marks a significant step forward in enhancing the safety and efficacy of prescription drugs across the U.S. pharmaceutical supply chain.
By November 27, 2024, the U.S. pharmaceutical supply chain must exchange product compliance information, including drug verification and tracing data, in a fully interoperable manner. To ensure seamless authentication and prevent bad actors from accessing sensitive information, LedgerDomain and ConsortiEX are providing a joint approach for trading partners based on specifications developed in close collaboration with industry stakeholders, including the Partnership for DSCSA Governance (PDG) the Healthcare Distribution Alliance (HDA) VRS Working Group, GS1 US, and the Open Credentialing Initiative (OCI).
“This strategic partnership is a key milestone in delivering DSCSA interoperability to our customers,” said Neal Long, ConsortiEX founder and CEO. “By leveraging our unique capabilities, ConsortiEX and LedgerDomain will be able to offer integrated services that can protect patient lives and improve hospital performance.”
LedgerDomain brings to the table their Drummond Certified™ XATP solution, which enables trading partners including global enterprises, health centers, and independent pharmacists to meet DSCSA requirements for authentication, enhanced verification, tracing, and more. ConsortiEX is renowned for its DSCSA Compliance as a Service and IV Workflow Management solutions.
“We’re excited to embark on this partnership with ConsortiEX,” said Ben Taylor, CEO of LedgerDomain. “This collaboration aligns perfectly with our mission to seamlessly connect trading partners via secure credentialed channels to meet the critical requirements stipulated by the DSCSA law.”
This strategic partnership is poised to expand the capabilities of both ConsortiEX and LedgerDomain, enabling them to support an even broader spectrum of healthcare facilities across the United States and improve how healthcare systems receive and manage their prescription drug inventories.
For more information, email LedgerDomain at info@ledgerdomain.com, or join them at booth 106 at HDA’s Distribution Management Conference and Expo, March 10-13, 2024, in Palm Desert, California.
About LedgerDomain
LedgerDomain is the identity and secure messaging platform for modern decentralized healthcare. Their Drummond Certified™ XATP solution enables trading partners, including global enterprises, health centers, and independent pharmacists, to comply with DSCSA requirements for authentication, enhanced verification, tracing, and more – helping prescription drugs remain safe and effective for patients.
For more information about LedgerDomain, visit https://ledgerdomain.com.
About ConsortiEX
ConsortiEX is a health care pharmacy IT company providing software and services to manage the ordering, production, distribution, and tracking of pharmaceuticals… from Pedigree to Patient®. DSCSA Compliance as a Service removes the compliance burden from Hospital Clinics and Pharmacies with comprehensive data collection and traceability services. Assure-Trak® integrates Batch and Dynamic Patient Specific compounding, tracking ingredients through production to patient administration.
For more information about ConsortiEX, visit https://consortiex.com.
